Decreased Expression of Sprouty2 in the Dorsolateral Prefrontal Cortex in Schizophrenia and Bipolar Disorder: A Correlation with BDNF Expression - Pillai, Anilkumar (PloS one, 2008)
Keywords: Abnormalities; Analysis; Animals; Antipsychotic Agents - therapeutic use; Antipsychotics; Base Sequence; Bipolar disorder; Bipolar Disorder - drug therapy; Bipolar Disorder - metabolism; Brain; Brain-derived neurotrophic factor; Brain-Derived Neurotrophic Factor - genetics; Brain-Derived Neurotrophic Factor - metabolism; Cellular signal transduction; Correlation; Cortex (frontal); DNA Primers; Drugs; Functional plasticity; Gene expression; Genes; Haloperidol; Humans; Intracellular Signaling Peptides and Proteins - genetics; Intracellular Signaling Peptides and Proteins - metabolism; Kinases; Male; Membrane Proteins; Mental disorders; Mental Health/Mood Disorders; Mental Health/Neuropsychiatric Disorders; Mental Health/Psychopharmacology; Mental Health/Schizophrenia and Other Psychoses; Myelination; Neural plasticity; Neuroplasticity; Neuroscience/Cognitive Neuroscience; Neuroscience/Neurodevelopment; Olanzapine; Prefrontal cortex; Prefrontal Cortex - metabolism; Psychotropic drugs; Rats; Regulatory mechanisms (biology); Reverse Transcriptase Polymerase Chain Reaction; Ribonucleic acid; RNA; RNA, Messenger - genetics; Rodents; Schizophrenia; Schizophrenia - drug therapy; Schizophrenia - metabolism; Signal transduction; Synaptic plasticity